{"id":17703,"date":"2021-10-11T13:45:47","date_gmt":"2021-10-11T12:45:47","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=17703"},"modified":"2021-10-11T13:45:51","modified_gmt":"2021-10-11T12:45:51","slug":"antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/","title":{"rendered":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires"},"content":{"rendered":"\n

ebmfrance.net<\/u><\/a>, le site de recommandations d\u00e9velopp\u00e9 par le Coll\u00e8ge de la M\u00e9decine G\u00e9n\u00e9rale et\u00a0Antibioclic<\/u><\/a>, le site de r\u00e9f\u00e9rence pour l\u2019aide \u00e0 la prescription antibiotique en soins primaires, sont partenaires pour offrir \u00e0 leurs utilisateurs des guides d\u00e9cisionnels cliniques et th\u00e9rapeutiques encore plus performants et simples d\u2019acc\u00e8s.<\/p>\n\n\n\n

Ces deux outils compl\u00e9mentaires sont d\u00e9sormais directement accessibles sur chacune des plateformes pour optimiser l\u2019exp\u00e9rience des utilisateurs. Ainsi, pour chaque guide d\u2019ebmfrance.net<\/u><\/a> o\u00f9 se pose la question d\u2019une antibioth\u00e9rapie, des liens directs sont propos\u00e9s vers les strat\u00e9gies th\u00e9rapeutiques d\u2019Antibioclic<\/u><\/a>. ebmfrance.net<\/u><\/a> est aussi directement accessible depuis la page d\u2019accueil d\u2019Antibioclic<\/u><\/a>.<\/p>\n\n\n\n

Antibioclic<\/u><\/strong><\/a><\/h4>\n\n\n\n

\u00c9labor\u00e9 par un comit\u00e9 d\u2019experts pluridisciplinaires (m\u00e9decins g\u00e9n\u00e9ralistes, infectiologues, professionnels de sant\u00e9 publique), Antibioclic<\/u><\/a> est un outil d\u2019aide \u00e0 la d\u00e9cision th\u00e9rapeutique en antibioth\u00e9rapie, destin\u00e9 aux professionnels de soins primaires. Il a pour objectif de permettre une antibioth\u00e9rapie rationnelle, d\u2019apr\u00e8s les recommandations des soci\u00e9t\u00e9s savantes fran\u00e7aises. Pour chaque situation infectieuse fr\u00e9quemment rencontr\u00e9e en soins primaires il existe une proposition th\u00e9rapeutique, adapt\u00e9e au profil du patient (grossesse, insuffisance r\u00e9nale, allaitement).<\/p>\n\n\n\n

ebmfrance.net<\/u><\/strong><\/a><\/h4>\n\n\n\n

ebmfrance.net<\/u><\/a> est port\u00e9 par le Coll\u00e8ge de la M\u00e9decine G\u00e9n\u00e9rale<\/u><\/a> en partenariat avec la HAS et financ\u00e9 par l\u2019Assurance Maladie, accessible aux m\u00e9decins g\u00e9n\u00e9ralistes et aux internes en m\u00e9decine g\u00e9n\u00e9rale. Plus de 1 000 guides de pratique clinique et recommandations valid\u00e9es scientifiquement (HAS<\/u><\/a>, INCa<\/u><\/a>, Duodecim<\/u><\/a>, Cochrane<\/u><\/a>, etc.) sont disponibles sur le site et actualis\u00e9es r\u00e9guli\u00e8rement. L\u2019ergonomie du site a \u00e9t\u00e9 pens\u00e9e afin de permettre une utilisation optimis\u00e9e en consultation, ce qui en fait un authentique outil d\u2019aide \u00e0 la d\u00e9cision m\u00e9dicale. L\u2019int\u00e9gration des recommandations d\u2019Antibioclic<\/u><\/a> est un plus pour les utilisateurs.<\/p>\n\n\n\n

T\u00e9l\u00e9charger le communiqu\u00e9<\/u><\/a><\/p>\n\n\n\n

Contacts :<\/p>\n\n\n\n

ebmfrance.net<\/u><\/em><\/a>
Antibioclic<\/u><\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

ebmfrance.net, le site de recommandations d\u00e9velopp\u00e9 par le Coll\u00e8ge de la M\u00e9decine G\u00e9n\u00e9rale et\u00a0Antibioclic, le site de r\u00e9f\u00e9rence pour l\u2019aide \u00e0 la prescription antibiotique en soins primaires, sont partenaires pour offrir \u00e0 leurs utilisateurs des guides d\u00e9cisionnels cliniques et th\u00e9rapeutiques encore plus performants et simples d\u2019acc\u00e8s. Ces deux outils compl\u00e9mentaires sont d\u00e9sormais directement accessibles sur […]<\/p>\n","protected":false},"author":139,"featured_media":17709,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"\nAntibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-11T12:45:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T12:45:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"919\" \/>\n\t<meta property=\"og:image:height\" content=\"573\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires\",\"datePublished\":\"2021-10-11T12:45:47+00:00\",\"dateModified\":\"2021-10-11T12:45:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\",\"name\":\"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg\",\"datePublished\":\"2021-10-11T12:45:47+00:00\",\"dateModified\":\"2021-10-11T12:45:51+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg\",\"width\":919,\"height\":573,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/","og_locale":"fr_FR","og_type":"article","og_title":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-10-11T12:45:47+00:00","article_modified_time":"2021-10-11T12:45:51+00:00","og_image":[{"width":919,"height":573,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires","datePublished":"2021-10-11T12:45:47+00:00","dateModified":"2021-10-11T12:45:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/"},"wordCount":362,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/","name":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg","datePublished":"2021-10-11T12:45:47+00:00","dateModified":"2021-10-11T12:45:51+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/10\/Pills-111021.jpg","width":919,"height":573,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/antibioclic-et-ebmfrance-net-sassocient-pour-faciliter-laide-a-la-decision-en-soins-primaires\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Antibioclic et ebmfrance.net s\u2019associent pour faciliter l\u2019aide \u00e0 la d\u00e9cision en soins primaires"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-14 17:51:23","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/17703"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=17703"}],"version-history":[{"count":7,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/17703\/revisions"}],"predecessor-version":[{"id":17721,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/17703\/revisions\/17721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/17709"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=17703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=17703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=17703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}